Use of Levetiracetam in Epileptic Dogs with Chronic Kidney Disease: A Retrospective Study
In human medicine, doses of levetiracetam (LEV) are individualized for patients with epilepsy, depending on the status of the patient’s renal function. However, there are not reports on the individualized dosing of LEV for small animals. The aim of this study is to investigate whether a dose adjustm...
Saved in:
Main Authors: | So-Yeon Gim, Woo-Jin Song, Hwa-Young Youn |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/c927cdfb5bae4d15bb24208d745b37db |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Response to Levetiracetam Treatment and Long-Term Follow-Up in Dogs With Reactive Seizures Due to Probable Exogenous Toxicity
by: Fabio Stabile, et al.
Published: (2021) -
Psychiatric Adverse Effects of Levetiracetam in Malignant Glioma Populations; a Retrospective Cohort Study
by: Paul Thisayakorn, et al.
Published: (2021) -
Comparative Efficacy of Levetiracetam for Epilepsy in School-Aged Children with Intellectual Disability and Normal Intelligence
by: Ja Un Moon, et al.
Published: (2021) -
Overnight switch from levetiracetam to brivaracetam. Safety and tolerability
by: L. Abraira, et al.
Published: (2021) -
Effects of Levetiracetam Compared to Valproate on Cognitive Functions of Patients with Epilepsy
by: El Sabaa RM, et al.
Published: (2020)